Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. […]
One of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer when mutated—are responsible for a quarter […]
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health links historic redlining, coupled with ongoing segregation by race and income, […]